Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam oral tablet bioequivalence and intravenous/oral bioavailability crossover study in healthy volunteers
NL-OMON38511Active, not recruiting
- Sponsor
- UCB
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of brivaracetam in epilepsy, sponsored by UCB. Primary endpoints: Plasma brivaracetam concentrations, Pharmacokinetic parameters and 1 more. Started Jan 2013; status: active, not recruiting.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON38511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38511.